What changed in TRINITY BIOTECH PLC's 2024 10-K compared to 2023?

Across the narrative sections we track, TRINITY BIOTECH PLC (TRIB) added 0 paragraphs, removed 0, and edited 0 between the 2023 and 2024 10-K filings. The biggest movers are .

Where does this TRIB 10-K diff come from?

The source filings are TRINITY BIOTECH PLC's official 2023 and 2024 Form 20-F annual reports from SEC EDGAR. 10q10k.net parses each filing, aligns paragraphs by section (Item 1, 1A, 1C, 2, 3, 7, 7A), and highlights every added, removed and edited sentence side-by-side.

TRINITY BIOTECH PLCTRIB财报

Nasdaq

Trinity Biotech PLC develops, manufactures and markets diagnostic test kits and systems for clinical laboratories and point-of-care settings. Its product portfolio covers diabetes management, infectious diseases, cardiac health, autoimmune disorders and coagulation, with core markets across North America, Europe and emerging economies.

What changed in TRINITY BIOTECH PLC's 20-F — 2023 vs 2024

No meaningful paragraph-level changes detected in the compared sections. Either the two filings are nearly identical or the sections did not parse.

Other TRIB 10-K year-over-year comparisons

TRIB 10-K 2022 vs 2023